C. Nurse

Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study

P. Busse, M. Maurer, M. Riedl, 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effect of Lanadelumab on Coagulation Parameters in Patients With Hereditary Angioedema: Findings From The Phase 3 HELP Study: 121

A. Schmaier, P. Busse, K. Bauer, 2019, Journal of Allergy and Clinical Immunology.

Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open‐label study

M. Hide, I. Ohsawa, M. Yu, 2023, The Journal of dermatology.